MWH Global Announces Sale Of MWH Laboratories To Eurofins Scientific

MWH Global will continue to offer water quality services through its research arm

MWH Global, the global wet infrastructure sector leader and provider of strategic consulting, environmental engineering and construction services, announced recently that it has signed a definitive agreement to sell MWH Laboratories to Eurofins Scientific, the world leader in analytical testing support to the global environmental sector.

MWH Laboratories is one of the largest water quality laboratory operations in the United States, providing technical services from its 34,000 square-foot-facility in Monrovia, Calif. The sale of MWH Laboratories is expected to leverage Eurofins global footprint, while complementing its testing services, capabilities and expertise for customers worldwide. Terms of the agreement were undisclosed.   

“MWH believes this move is beneficial for our laboratory clients and employees,” said Daniel McConville, president of MWH business solutions group operations. “Eurofins shares our commitment to water quality, and Eurofins leadership has committed to further expanding service capabilities and enhancing the role of this laboratory as a leader in water quality analytics. We will work with Eurofins to achieve a smooth transition for employees and our clients.”

“Bringing MWH Laboratories’ level of technical sophistication in drinking water analyses into the Eurofins international portfolio is part of an ongoing strategy to add best-in-class capabilities and ultimately provide the absolute best service to our customers,” said Dr. J. Wilson Hershey, chairman of Eurofins Lancaster Laboratories.

Eurofins intends to retain MWH Laboratories management and staff as part of the sale. There are more than 100 employees working at MWH Laboratories. MWH and Eurofins will work together to allow MWH and its clients to benefit from the laboratory and testing service offerings of Eurofins.

MWH will continue to serve clients and offer water quality services through its research arm, led by Dr. Joseph Jacangelo, vice president and director of research. Of note, the MWH research team has led innovative industry research on membrane technology and energy management. With a focus on environmental planning and assessment, MWH research experts have also collaborated on international studies about the energy optimization of water distribution networks and wastewater collection systems. 

Immediately following regulatory review and approval, MWH Laboratories will become Eurofins Eaton Analytics, named for Dr. Andrew Eaton, a 32-year veteran at MWH Laboratories, in honor of his industry leadership in water quality analysis and testing. 

About MWH
MWH Global is a strategic consulting, technical engineering and construction services firm leading the wet infrastructure sector. Offering a full range of services and innovative, award-winning solutions beginning in the initial planning phases through construction and asset management, we partner with our clients in multiple industries to implement projects and programs that focus on water, energy, natural resources and infrastructure. Our 7,500 employees in 35 countries spanning six continents are dedicated to fulfilling our purpose of Building a Better World, which reflects our commitment to sustainable development. MWH is a private, employee-owned firm with a rich legacy beginning in 1820. For more information, visit our website at www.mwhglobal.com.

About Eurofins
Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics and central laboratory services.

With over 12,000 staff in more than 170 laboratories across 32 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high quality services, accurate results in time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).